Ben R. Taylor, Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 25,334 shares at $3.08 ($83K) on 2026-02-18, disclosed to the SEC on 2026-02-19.
Scheduled sale ($83k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.49 | 11,908 | $42K | 50.1% |
| 2 | $3.08 | 13,426 | $41K | 49.9% |
| Total | $3.27 avg | 25,334 | $83K | 100% |
| Filing → |
| TYME | BUY | 2019-06-17 | $10K | — | Filing → |